Melola Discovery

← Melola Discovery

Jurnal SINTA 1

The Effect of Garcinia Mangostana Linn Extract to The Levels of Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with High Framingham Score

Heart Science Journal · Vol. 1 No. 2 (2020) · hlm. 32–37

DOI
10.21776/ub.hsj.2020.001.02.6
ISSN
2721-9984, 2721-9976
Terbit
2020-07-22
Penerbit
Universitas Brawijaya
Bahasa
en

Abstrak

Background: Recently, studies have concerned on the use of xanthones for treating patients with cardiovascular diseases. In our country, xanthones were found in Garcinia Mangostana Linn.Objectives: To assess the effect of Garcinia Mangostana Linn Extract (GMLE) to the levels of Circulating Endothelial Cells (CEC) and Endothelial Progenitor Cells (EPC) in patients with high framingham score.Methods: A prospective cohort study was conducted from November 2018 to January 2019. The patients were divided into two groups. The first group was given 2520 mg/day of GMLE for 90 days and the second group was given placebo. In sub group analyses, patients were divided based on previous medication, including statin, statin and angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB), statin and oral antidiabetic drugs (OAD), and statin and ACEI or ARB and OAD. The outcome measures were CEC and EPC levels, measured at baseline and after 90 days of treatment. We used multiple linear regression to analyze the correlation and effect estimates.Results: A total of 72 patients was included in our study. All of the patients baseline characteristics were distributed homogeneously (p>0.05). Our findings confirmed that GMLE administration was associated with decreased CEC level compared to placebo. On other hands, increased EPC level compared to placebo was observed after GMLE administration. In sub-group analyses, our study found that the combination of GMLE with statin and ACEI or ARB and the combination of GMLE with statin and ACEI or ARB and OAD were associated with decreased level of CEC compared to placebo, with the odd ratios were 0.12 and 0.18, respectively. Conversely, increased level of EPC was observed in subjects receiving the combination of GMLE with statin and ACEI or ARB and the combination of GMLE with statin.Conclusion: Administration of GMLE as adjuvant therapy is associated with the improvement of CEC and EPC levels in patients with high framingham scores.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 307 tautan kepenulisan bersama · 5 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • RSUD Prof. Dr. Saiful Anwar Malang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Indra PrasetyaUniversity of Brawijaya44
Cholid Tri TjahjonoUniversity of Brawijaya42
Novi KurnianingsihUniversity of Brawijaya36
Setyasih AnjarwaniUniversity of Brawijaya34
Budi SatrijoUniversity of Brawijaya27
Djanggan SargowoUniversity of Brawijaya24
Sasmojo WiditoUniversity of Brawijaya23
Yoga WaranugrahaUniversity of Brawijaya16
Wella KarolinaUniversity of Brawijaya15
Valerinna YogibuanaAfiliasi tidak diketahui12
Adhika Prastya WikanandaUniversity of Brawijaya10
Tri AstiawatiUniversity of Brawijaya9
Nikhen NoverikeUniversity of Brawijaya8
Muhammad Rizki FadlanUniversity of Brawijaya7
Valerinna Yogibuana Swastika PutriUniversity of Brawijaya7
Putri Annisa KamilaUniversity of Brawijaya6
Fandy HazzyUniversity of Brawijaya6
Lukitasari Ayu Galuh ArdhiUniversity of Brawijaya6
Fahmy RusnantaUniversity of Brawijaya6
Ratna PancasariUniversity of Brawijaya6
Seprian WidasmaraUniversity of Brawijaya6
Olivia HandayaniUniversity of Brawijaya5
Ayu Asri Devi AdityawatiUniversity of Brawijaya5
Indra Jabbar AzizUniversity of Brawijaya5
Dadang HendrawanUniversity of Brawijaya4
Oktafin Srywati PamunaUniversity of Brawijaya4
Imelda KrisnasariUniversity of Brawijaya4
Danti Utami SetyowatiRSUD Prof. Dr. Saiful Anwar Malang4
Dea Arie KurniawanUniversity of Brawijaya4
Hayla Iqda MillisaniUniversity of Brawijaya3
Anna Fuji RahimahAfiliasi tidak diketahui3
Teguh AryanugrahaUniversity of Brawijaya3
Lutfi Hafiz ZunardiUniversity of Brawijaya3

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The Effect of Garcinia Mangostana Linn Extract to The Levels of Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with High Framingham Score</dc:title>
	<dc:creator xml:lang="en">Maulana, Aditha Satria</dc:creator>
	<dc:creator xml:lang="en">Sargowo, Djanggan</dc:creator>
	<dc:creator xml:lang="en">Rizal, Ardian</dc:creator>
	<dc:creator xml:lang="en">Martini, Heny</dc:creator>
	<dc:creator xml:lang="en">Rohman, Mohammad Saifur</dc:creator>
	<dc:creator xml:lang="en">Rahimah, Anna Fuji</dc:creator>
	<dc:creator xml:lang="en">Fajar, Jonny Karunia</dc:creator>
	<dc:subject xml:lang="en">Garcinia mangostana L. extract</dc:subject>
	<dc:subject xml:lang="en">Circulating endothelial cells</dc:subject>
	<dc:subject xml:lang="en">Endothelial progenitor cells</dc:subject>
	<dc:description xml:lang="en">Background : Recently, studies have concerned on the use of xanthones for treating patients with cardiovascular diseases. In our country, xanthones were found in Garcinia Mangostana Linn.Objectives : To assess the effect of Garcinia Mangostana Linn Extract (GMLE) to the levels of Circulating Endothelial Cells (CEC) and Endothelial Progenitor Cells (EPC) in patients with high framingham score.Methods : A prospective cohort study was conducted from November 2018 to January 2019. The patients were divided into two groups. The first group was given 2520 mg/day of GMLE for 90 days and the second group was given placebo. In sub group analyses, patients were divided based on previous medication, including statin, statin and angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB), statin and oral antidiabetic drugs (OAD), and statin and ACEI or ARB and OAD. The outcome measures were CEC and EPC levels, measured at baseline and after 90 days of treatment. We used multiple linear regression to analyze the correlation and effect estimates.Results: A total of 72 patients was included in our study. All of the patients baseline characteristics were distributed homogeneously (p&amp;gt;0.05). Our findings confirmed that GMLE administration was associated with decreased CEC level compared to placebo. On other hands, increased EPC level compared to placebo was observed after GMLE administration. In sub-group analyses, our study found that the combination of GMLE with statin and ACEI or ARB and the combination of GMLE with statin and ACEI or ARB and OAD were associated with decreased level of CEC compared to placebo, with the odd ratios were 0.12 and 0.18, respectively. Conversely, increased level of EPC was observed in subjects receiving the combination of GMLE with statin and ACEI or ARB and the combination of GMLE with statin.Conclusion: Administration of GMLE as adjuvant therapy is associated with the improvement of CEC and EPC levels in patients with high framingham scores.</dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2020-07-22</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/58</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2020.001.02.6</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 1 No. 2 (2020): The Assessment of Diagnostic and Treatment Modality in Heart Failure; 32-37</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2020.001.02</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/58/327</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2020 Heart Science Journal</dc:rights>
</oai_dc:dc>